Assignee
ARSANIS BIOSCIENCES GMBH
AT·4 granted patents·9 pending applications·25 citations·filing 2013–2017
Top patents by PatentIndex Score
13 records- 0190US10206992B2MDR E. coli specific antibodyARSANIS BIOSCIENCES GMBH·Filed 2016·Granted Feb 19, 2019·9 cites·23 claims
- 0289US9849169B2MDR E. coli specific antibodyARSANIS BIOSCIENCES GMBH·Filed 2014·Granted Dec 26, 2017·13 cites·5 claims
- 0369US9914767B2Cross-reactive Staphylococcus aureus antibodyARSANIS BIOSCIENCES GMBH·Filed 2013·Granted Mar 13, 2018·3 cites·21 claims
- 0448US10759848B2Klebsiella pneumoniae O3 specific antibodiesARSANIS BIOSCIENCES GMBH·Filed 2017·Granted Sep 1, 2020·0 cites·19 claims
- 0542US2016244511A1Cross-reactive staphylococcus aureus antibody sequencesARSANIS BIOSCIENCES GMBH·Filed 2014·Application pending·0 cites
- 0642US2016340415A1ANTIBODIES DIRECTED AGAINST THE LukGH (LukAB) TOXIN OF STAPHYLOCOCCUS AUREUS AND ANTIBODY SEQUENCESARSANIS BIOSCIENCES GMBH·Filed 2014·Application pending·0 cites
- 0740US2018298084A1Bactericidal monoclonal antibody targeting klebsiella pneumoniaeARSANIS BIOSCIENCES GMBH·Filed 2016·Application pending·0 cites
- 0839US2016108106A1Generation of highly potent antibodies neutralizing the lukgh (lukab) toxin of staphylococcus aureusARSANIS BIOSCIENCES GMBH·Filed 2014·Application pending·0 cites
- 0936US2018312576A1Antibodies targeting a mannan-based o-antigen of k. pneumoniaeARSANIS BIOSCIENCES GMBH·Filed 2016·Application pending·0 cites
- 1035US2019161534A1Anti-galactan ii monoclonal antibodies targeting klebsiella pneumoniaeARSANIS BIOSCIENCES GMBH·Filed 2017·Application pending·0 cites
- 1130US2018105584A1Antibody directed against immunoglobulin-binding proteins of s. aureusARSANIS BIOSCIENCES GMBH·Filed 2016·Application pending·0 cites
- 1229US2018017559A1Predicting s. aureus diseaseARSANIS BIOSCIENCES GMBH·Filed 2015·Application pending·0 cites
- 1329US2018179267A1Anti-staphylococcus aureus antibody combination preparationARSANIS BIOSCIENCES GMBH·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →